L B L Benoist1,2, M Verhagen3, B Torensma4, J P van Maanen3, N de Vries3,4,5,6. 1. Department of Otolaryngology Head and Neck Surgery, OLVG west, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands. l.benoist@erasmusmc.nl. 2. Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands. l.benoist@erasmusmc.nl. 3. Department of Otolaryngology Head and Neck Surgery, OLVG west, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands. 4. Department of Epidemiology and Biostatistics, OLVG west, Amsterdam, The Netherlands. 5. Department of Oral Kinesiology ACTA, Amsterdam, The Netherlands. 6. Department of Otolaryngology Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium.
Abstract
PURPOSE/ BACKGROUND: A considerable portion of patients has residual positional obstructive sleep apnea (POSA) after upper airway surgery. Those patients could benefit from additional treatment with positional therapy (PT). The objective of this prospective study was to assess the additional effect of PT in patients with residual POSA after upper airway surgery for sleep apnea. METHODS: A polysomnography (PSG) was used to diagnose a patient with residual POSA after surgery. After informed consent, patients were treated with PT for 3 months and underwent a follow-up PSG while using the sleep position trainer (SPT). Changes in apnea-hypopnea index (AHI) and sleep position parameters were analyzed. Compliance rates and mean disease alleviation (MDA) were determined. RESULTS: Thirty-three patients with a median postoperative AHI of 18.3/h sleep were included. With the SPT median AHI dropped to 12.5/h sleep and the Epworth Sleepiness Scale (ESS) improved from 10.0 to 7.0. After 3 months, 37.5 % patients were considered responders of whom 31.3 % had treatment success. The compliance rate with SPT was 89.0 %. MDA was 44.7 % for SPT alone. With the combination of both surgery and SPT, MDA was 65.6 %. CONCLUSIONS: The results of this study indicate that additional PT in a complex OSA patient population with residual POSA after surgery can increase overall therapeutic effectiveness by improving the median MDA from 39.5 % (effect of surgery alone) to 65.6 % (effect of combining surgery and PT).
PURPOSE/ BACKGROUND: A considerable portion of patients has residual positional obstructive sleep apnea (POSA) after upper airway surgery. Those patients could benefit from additional treatment with positional therapy (PT). The objective of this prospective study was to assess the additional effect of PT in patients with residual POSA after upper airway surgery for sleep apnea. METHODS: A polysomnography (PSG) was used to diagnose a patient with residual POSA after surgery. After informed consent, patients were treated with PT for 3 months and underwent a follow-up PSG while using the sleep position trainer (SPT). Changes in apnea-hypopnea index (AHI) and sleep position parameters were analyzed. Compliance rates and mean disease alleviation (MDA) were determined. RESULTS: Thirty-three patients with a median postoperative AHI of 18.3/h sleep were included. With the SPT median AHI dropped to 12.5/h sleep and the Epworth Sleepiness Scale (ESS) improved from 10.0 to 7.0. After 3 months, 37.5 % patients were considered responders of whom 31.3 % had treatment success. The compliance rate with SPT was 89.0 %. MDA was 44.7 % for SPT alone. With the combination of both surgery and SPT, MDA was 65.6 %. CONCLUSIONS: The results of this study indicate that additional PT in a complex OSA patient population with residual POSA after surgery can increase overall therapeutic effectiveness by improving the median MDA from 39.5 % (effect of surgery alone) to 65.6 % (effect of combining surgery and PT).
Authors: Kate Sutherland; Olivier M Vanderveken; Hiroko Tsuda; Marie Marklund; Frederic Gagnadoux; Clete A Kushida; Peter A Cistulli Journal: J Clin Sleep Med Date: 2014-02-15 Impact factor: 4.062
Authors: Marijke Dieltjens; Anneclaire V Vroegop; Annelies E Verbruggen; Kristien Wouters; Marc Willemen; Wilfried A De Backer; Johan A Verbraecken; Paul H Van de Heyning; Marc J Braem; Nico de Vries; Olivier M Vanderveken Journal: Sleep Breath Date: 2014-10-22 Impact factor: 2.816
Authors: C Kastoer; L B L Benoist; M Dieltjens; B Torensma; L H de Vries; P E Vonk; M J L Ravesloot; N de Vries Journal: Sleep Breath Date: 2018-08-01 Impact factor: 2.816
Authors: Eric J Kezirian; Michael Simmons; Richard J Schwab; Peter Cistulli; Kasey K Li; Edward M Weaver; Andrew N Goldberg; Atul Malhotra Journal: Am J Respir Crit Care Med Date: 2020-12-01 Impact factor: 21.405
Authors: Jolien Beyers; Marijke Dieltjens; Chloé Kastoer; Lynn Opdebeeck; An N Boudewyns; Ilse De Volder; Ann Van Gastel; Johan A Verbraecken; Wilfried A De Backer; Marc J Braem; Paul H Van de Heyning; Olivier M Vanderveken Journal: J Clin Sleep Med Date: 2018-04-15 Impact factor: 4.062
Authors: Patty E Vonk; Perry J Rotteveel; Madeline J L Ravesloot; Jean-Pierre T F Ho; Jan de Lange; Nico de Vries Journal: J Clin Sleep Med Date: 2019-11-27 Impact factor: 4.062
Authors: Maria V Suurna; Ofer Jacobowitz; Jolie Chang; Ioannis Koutsourelakis; David Smith; Uri Alkan; Mark D'Agostino; Maurits Boon; Clemens Heiser; Paul Hoff; Colin Huntley; David Kent; Alan Kominsky; Richard Lewis; Joachim T Maurer; Madeline J Ravesloot; Ryan Soose; Armin Steffen; Edward M Weaver; Amy M Williams; Tucker Woodson; Kathleen Yaremchuk; Stacey L Ishman Journal: J Clin Sleep Med Date: 2021-12-01 Impact factor: 4.062